Explore approved biosimilar medicines
| # | Medicine | Status | Active Substance | Therapeutic Area | Developer | Published Date |
|---|---|---|---|---|---|---|
| 51 | Kefdensis | Authorised | denosumab | Bone Resorption;Osteoporosis;Osteoporosis, Postmenopausal | Stada Arzneimittel AG | 19-09-2025 |
| 52 | Afqlir | Authorised | aflibercept | Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion | Sandoz GmbH | 20-09-2024 |
| 53 | Nivestim | Authorised | filgrastim | Hematopoietic Stem Cell Transplantation;Cancer | Pfizer Europe MA EEIG | 23-08-2018 |
| 54 | Retacrit | Authorised | epoetin zeta | Anemia;Blood Transfusion, Autologous;Kidney Failure, Chronic;Cancer | Pfizer Europe MA EEIG | 03-08-2018 |
| 55 | Bysumlog | Opinion | insulin lispro | Diabetes Mellitus | Gan & Lee Pharmaceuticals Europe GmbH | 27-02-2026 |
| 56 | Conexxence | Authorised | denosumab | Osteoporosis;Osteoporosis, Postmenopausal;Bone Resorption | Fresenius Kabi Deutschland GmbH | 23-05-2025 |
| 57 | Yesafili | Authorised | aflibercept | Macular Edema;Retinal Vein Occlusion;Diabetic Retinopathy;Myopia, Degenerative;Diabetes Complications | Biosimilar Collaborations Ireland Limited | 17-07-2023 |
| 58 | Byooviz | Authorised | ranibizumab | Wet Macular Degeneration;Macular Edema;Diabetic Retinopathy;Myopia, Degenerative | Samsung Bioepis NL B.V. | 23-06-2021 |
| 59 | Gotenfia | Authorised | golimumab | Arthritis, Rheumatoid;Arthritis, Juvenile;Arthritis, Psoriatic;Axial Spondyloarthritis;Non-Radiographic Axial Spondyloarthritis;Colitis, Ulcerative | Stada Arzneimittel AG | 12-12-2025 |
| 60 | Vivlipeg | Authorised | pegfilgrastim | Neutropenia;Febrile Neutropenia;Chemotherapy-Induced Febrile Neutropenia;Cancer | Biosimilar Collaborations Ireland Limited | 02-10-2025 |
Ready to transform your strategic intelligence? Let's talk
Get latest pharmaceutical insights, blogs, and strategic updates directly in your inbox.